MedTrace Logo

Reoxygenation After Cardiac Arrest (REOX Study)

NCT01881243 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 280

Last updated 2019-11-25

No results posted yet for this study

Summary

The broad objective of this study is to test the association between hyperoxia exposure after resuscitation from cardiac arrest and outcome. Our overarching hypothesis is that hyperoxia after ROSC is associated with increased oxidative stress and worsened neurological and cognitive outcomes.

Conditions

  • Cardiac Arrest

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • The Cooper Health System

    lead OTHER

Principal Investigators

  • Stephen Trzeciak, MD, MPH · The Cooper Health System

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01881243 on ClinicalTrials.gov